- FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents ( )
- FTC Staff Sends Warning Letters to Healthcare Plan Marketers and Lead Generators ( )
- FTC Approves Modification of Cooperativa De Farmacias Puertorriqueñas Final Commission Order ( )
- Statement Regarding Union Health’s COPA Application Withdrawal ( )
- FTC Sends More Than $1.1 Million in Refunds to Consumers Deceived by Bait-and-Switch Ads for LASIK Vision Correction Procedures ( )
- FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices ( )
- FTC Staff Opposes Proposed Indiana Hospital Merger ( )
- FTC Seeks Public Comments on Cooperativa De Farmacias Puertorriqueñas Request to Modify Final Commission Order ( )
- FTC Submits Comment Supporting Proposed FDA Guidance on Interchangeable Biosimilar Drugs ( )
- FTC Submits Comment Supporting Proposed USPTO Terminal Disclaimer Rule ( )
- FTC Releases Interim Staff Report on Prescription Drug Middlemen ( )
- Statement Regarding the Termination of Novant Health’s Acquisition of Hospitals from Community Health Systems ( )
- FTC Announces Final Eyeglass Rule Implementing Updates to Promote Competition and Expand Consumer Choice ( )
- FTC Submits Comment Supporting Proposed USPTO Rule ( )
- FTC Releases Fiscal Year 2023 Annual Report ( )
- FTC, DOJ, and HHS Extend Comment Period on Cross-Government Inquiry on Impact of Corporate Greed in Health Care ( )
- FTC Expands Patent Listing Challenges, Targeting More Than 300 Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs ( )
- Federal Agencies Launch Portal for Public Reporting of Anticompetitive Practices in the Health Care Sector ( )
- Alcohol Addiction Treatment Firm will be Banned from Disclosing Health Data for Advertising to Settle FTC Charges that It Shared Data Without Consent ( )
- FTC, HHS Extend Public Comment Period on Generic Drug Shortages and Competition Request for Information ( )
- Federal Trade Commission, the Department of Justice and the Department of Health and Human Services Launch Cross-Government Inquiry on Impact of Corporate Greed in Health Care ( )
- FTC Hosts March 5 Virtual Workshop on Private Equity in Health Care ( )
- FTC Releases Agenda for Virtual Workshop on Private Equity in Health Care ( )
- FTC Action Leads to Ban for Company and Its Owner Who Failed to Ship PPE ‘Next Day’ at Height of Pandemic ( )
- FTC Sends Almost 160,000 Claim Forms to Consumers Who Could Receive Money Under a Settlement with LasikPlus Providers Over Deceptive Price Advertising ( )
- FTC to Host Virtual Workshop on Private Equity in Health Care ( )
- FTC, HHS Seek Public Comment on Generic Drug Shortages and Competition Amongst Powerful Middlemen ( )
- FTC Obtains $195 Million Judgment, Permanent Ban on Telemarketing and Selling Healthcare Products Against Simple Health Over Charges It Sold Sham Health Insurance ( )
- FTC Submits Comment on March-In Rights to Promote Efforts to Lower Drug Prices ( )
- FTC Sues to Block Novant Health’s Acquisition of Two Hospitals from Community Health Systems ( )
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.